Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,862,069
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
25,405,469
-
Shares change
-
-992,801
-
Total reported value, excl. options
-
$436,645,635
-
Value change
-
-$15,432,144
-
Number of buys
-
34
-
Number of sells
-
20
-
Price
-
$17.19
Institutional Holders of HilleVax, Inc. - Common Stock (HLVX) as of Q2 2023
As of 30 Jun 2023 HilleVax, Inc. - Common Stock (HLVX) had 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,405,469 shares of stock of the company.
Largest 10 holders included Frazier Life Sciences Management, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Carlyle Group Inc., T. Rowe Price Investment Management, Inc., FRANKLIN RESOURCES INC, BlackRock Inc., BRAIDWELL LP, VANGUARD GROUP INC, StepStone Group LP, and Samsara BioCapital, LLC.
This table shows 54 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.